Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



An audit of clinical trials registered at clinical trial registry of India in 2017

Ashwin K Panchasara, Hiren M Chawda.




Abstract

Background: Clinical trial registry of India (CTRI) was launched in 2007. In this audit, we tried to assess the clinical research scenario over last year by looking at the information about clinical studies registered at the CTRI from January 1, 2017, to December 31, 2017.

Aims and Objectives: We undertook this audit of clinical trials registered at the CTRI.

Materials and Methods: We accessed the official website of the CTRI, i.e., www.ctri.nic.in, and the required information was collected and descriptive statistics were used.

Results: We found a total of 3433 studies were registered from January 2017 to December 2017. Majority of the studies were of interventional in nature as compared to observational and bioavailability and bioequivalence studies. Majority of the studies were Phase 3, Phase 2 followed by Phase 4 and Phase 1.

Conclusion: The clinical research in the country has improved in 2017 as compared to last decade even though decrease in pharmaceutical industry studies. This could be due to increase in research institutes, medical colleges, investigator, and government-funded studies.

Key words: Clinical Trial Registry of India; Clinical Research; India; Clinical Trial






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.